[Comparative bioavailability of eicosapentaenoic acid and docasahexaenoic acid from triglycerides, free fatty acids and ethyl esters in volunteers]
- PMID: 2144420
[Comparative bioavailability of eicosapentaenoic acid and docasahexaenoic acid from triglycerides, free fatty acids and ethyl esters in volunteers]
Abstract
Comparative Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid from Triglycerides, Free Fatty Acids and Ethyl Esters in Volunteers. The bioavailability of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) from triglycerides, free fatty acids and ethyl esters was investigated in 8 female volunteers in a randomized triple cross-over trial with baseline control. EPA/DHA was administered in capsules in form of triglycerides (1.68/0.72 g), free fatty acids (1.35/1.065 g) and ethyl esters (1.86/1.27 g). The resulting EPA/DHA plasma levels were determined and evaluated. The mean relative bioavailability of EPA/DHA compared to triglycerides was 186/136% from free fatty acids and 40/48% from ethyl esters. Maximal plasma levels were about 50% higher with free fatty acids and about 50% lower with ethyl esters as compared to triglycerides. The tolerability of the free fatty acids was much worse than that of triglycerides and ethyl esters. The main side effect was eructation.
Similar articles
-
Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study.Vasc Health Risk Manag. 2013;9:563-73. doi: 10.2147/VHRM.S50464. Epub 2013 Oct 1. Vasc Health Risk Manag. 2013. PMID: 24124374 Free PMC article. Clinical Trial.
-
Bioavailability of marine n-3 fatty acid formulations.Prostaglandins Leukot Essent Fatty Acids. 2010 Sep;83(3):137-41. doi: 10.1016/j.plefa.2010.06.007. Prostaglandins Leukot Essent Fatty Acids. 2010. PMID: 20638827 Clinical Trial.
-
Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters.Eur J Clin Nutr. 2011 Feb;65(2):247-54. doi: 10.1038/ejcn.2010.239. Epub 2010 Nov 10. Eur J Clin Nutr. 2011. PMID: 21063431 Clinical Trial.
-
Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.Herz. 2004 Nov;29(7):673-85. doi: 10.1007/s00059-004-2602-4. Herz. 2004. PMID: 15580322 Review.
-
Microdetermination of fatty acids by gas chromatography and cardiovascular risk stratification by the "EPA+DHA level".Herz. 2006 Dec;31 Suppl 3:30-49. Herz. 2006. PMID: 17575804 Review.
Cited by
-
The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia.Lipids Health Dis. 2016 Jul 22;15(1):118. doi: 10.1186/s12944-016-0286-4. Lipids Health Dis. 2016. PMID: 27444154 Free PMC article. Review.
-
Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study.Vasc Health Risk Manag. 2013;9:563-73. doi: 10.2147/VHRM.S50464. Epub 2013 Oct 1. Vasc Health Risk Manag. 2013. PMID: 24124374 Free PMC article. Clinical Trial.
-
Cancer Related Anemia: An Integrated Multitarget Approach and Lifestyle Interventions.Nutrients. 2021 Feb 1;13(2):482. doi: 10.3390/nu13020482. Nutrients. 2021. PMID: 33535496 Free PMC article. Review.
-
Cholestane as a digestibility marker in the absorption of polyunsaturated fatty acid ethyl esters in Atlantic salmon.Lipids. 1992 Jun;27(6):418-24. doi: 10.1007/BF02536382. Lipids. 1992. PMID: 1630276
-
Effect of 1- and 2-Month High-Dose Alpha-Linolenic Acid Treatment on 13 C-Labeled Alpha-Linolenic Acid Incorporation and Conversion in Healthy Subjects.Mol Nutr Food Res. 2018 Oct;62(20):e1800271. doi: 10.1002/mnfr.201800271. Epub 2018 Sep 19. Mol Nutr Food Res. 2018. PMID: 30102841 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials